State Street’s Ultralife ULBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $268K | Sell |
42,470
-350
| -0.8% | -$2.36K | ﹤0.01% | 3744 |
|
|
2026
Q1 | $279K | Buy |
42,820
+2,100
| +5% | +$13.1K | ﹤0.01% | 3806 |
|
|
2025
Q4 | $233K | Hold |
40,720
| – | – | ﹤0.01% | 3867 |
|
|
2025
Q3 | $278K | Buy |
40,720
+3,100
| +8% | +$23.5K | ﹤0.01% | 3812 |
|
|
2025
Q2 | $338K | Sell |
37,620
-88,971
| -70% | -$527K | ﹤0.01% | 3703 |
|
|
2025
Q1 | $681K | Hold |
126,591
| – | – | ﹤0.01% | 3521 |
|
|
2024
Q4 | $943K | Buy |
126,591
+9,004
| +8% | +$74K | ﹤0.01% | 3499 |
|
|
2024
Q3 | $1.06M | Sell |
117,587
-5,738
| -5% | -$59.2K | ﹤0.01% | 3472 |
|
|
2024
Q2 | $1.31M | Buy |
123,325
+75,105
| +156% | +$800K | ﹤0.01% | 3432 |
|
|
2024
Q1 | $425K | Sell |
48,220
-1,500
| -3% | -$12.2K | ﹤0.01% | 3693 |
|
|
2023
Q4 | $339K | Sell |
49,720
-6,200
| -11% | -$50.9K | ﹤0.01% | 3741 |
|
|
2023
Q3 | $546K | Buy |
55,920
+16,500
| +42% | +$132K | ﹤0.01% | 3646 |
|
|
2023
Q2 | $191K | Hold |
39,420
| – | – | ﹤0.01% | 4021 |
|
|
2023
Q1 | $158K | Hold |
39,420
| – | – | ﹤0.01% | 4155 |
|
|
2022
Q4 | $152K | Sell |
39,420
-700
| -2% | -$3.23K | ﹤0.01% | 4222 |
|
|
2022
Q3 | $193K | Hold |
40,120
| – | – | ﹤0.01% | 4156 |
|
|
2022
Q2 | $183K | Hold |
40,120
| – | – | ﹤0.01% | 4245 |
|
|
2022
Q1 | $215K | Buy |
40,120
+2,596
| +7% | +$13.9K | ﹤0.01% | 4355 |
|
|
2021
Q4 | $227K | Hold |
37,524
| – | – | ﹤0.01% | 4291 |
|
|
2021
Q3 | $265K | Buy |
37,524
+8,900
| +31% | +$71.7K | ﹤0.01% | 4252 |
|
|
2021
Q2 | $240K | Sell |
28,624
-102,854
| -78% | -$885K | ﹤0.01% | 4146 |
|
|
2021
Q1 | $1.09M | Buy |
131,478
+2,795
| +2% | +$19.8K | ﹤0.01% | 3605 |
|
|
2020
Q4 | $833K | Buy |
128,683
+35,585
| +38% | +$225K | ﹤0.01% | 3589 |
|
|
2020
Q3 | $549K | Buy |
93,098
+1,800
| +2% | +$11.8K | ﹤0.01% | 3556 |
|
|
2020
Q2 | $640K | Buy |
+91,298
| New | +$667K | ﹤0.01% | 3508 |
|
|
2020
Q1 | – | Sell |
-13,350
| Closed | -$99K | – | 3791 |
|
|
2019
Q4 | $99K | Buy |
13,350
+2,459
| +23% | +$20.4K | ﹤0.01% | 3684 |
|
|
2019
Q3 | $94K | Buy |
10,891
+205
| +2% | +$1.75K | ﹤0.01% | 3676 |
|
|
2019
Q2 | $85K | Buy |
+10,686
| New | +$97.2K | ﹤0.01% | 3681 |
|
|
2019
Q1 | – | Sell |
-10,116
| Closed | -$68K | – | 3760 |
|
|
2018
Q4 | $68K | Sell |
10,116
-342
| -3% | -$2.49K | ﹤0.01% | 3659 |
|
|
2018
Q3 | $84K | Buy |
+10,458
| New | +$97.7K | ﹤0.01% | 3663 |
|
Other funds holding ULBI
VWA
THC
RC
State Street's ULBI Position: Q2 2026 in Review
State Street reduced its Ultralife (ULBI) stake by 0.82% in Q2 2026, selling an estimated $2.36K and leaving 42,470 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #3744.
State Street first reported a position in ULBI in Q3 2018 and has held it in 30 quarters since. The position peaked at $1.31M in Q2 2024. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.
- State Street held 42,470 shares of Ultralife worth $268K as of Q2 2026.
- State Street sold 350 Ultralife shares in Q2 2026, an estimated $2.36K.
- Ultralife made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3744 holding.
- State Street first reported a position in Ultralife in Q3 2018 and has held it in 30 quarters since.
- State Street's Ultralife position peaked at $1.31M in Q2 2024.
- 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.